These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Predicting first-year relapses in children with nephrotic syndrome. Constantinescu AR; Shah HB; Foote EF; Weiss LS Pediatrics; 2000 Mar; 105(3 Pt 1):492-5. PubMed ID: 10699098 [TBL] [Abstract][Full Text] [Related]
28. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'? Doe JY; Funk M; Mengel M; Doehring E; Ehrich JH Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742 [TBL] [Abstract][Full Text] [Related]
29. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome. Jones DP; Stapleton FB; Roy S; Wyatt RJ Pediatr Nephrol; 1988 Jul; 2(3):291-5. PubMed ID: 3153028 [TBL] [Abstract][Full Text] [Related]
30. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie. Lancet; 1988 Feb; 1(8582):380-3. PubMed ID: 2893190 [TBL] [Abstract][Full Text] [Related]
31. New insights into treatment of nephrotic syndrome in children. Wang X; Xu H Contrib Nephrol; 2013; 181():119-30. PubMed ID: 23689574 [TBL] [Abstract][Full Text] [Related]
32. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties]. Cagnoli L; G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502 [TBL] [Abstract][Full Text] [Related]
33. [Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types]. Xia ZK; Liu GL; Gao YF; Fu J; Fu YF; Zhang LF; Fan ZM Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):813-6. PubMed ID: 14728885 [TBL] [Abstract][Full Text] [Related]
34. An analysis of the approach to management of childhood nephrotic syndrome by pediatric nephrologists. Primack WA; Schulman SL; Kaplan BS Am J Kidney Dis; 1994 Apr; 23(4):524-7. PubMed ID: 8154487 [TBL] [Abstract][Full Text] [Related]
35. Linear growth of children with nephrotic syndrome: effect of alkylating agents. Padilla R; Brem AS Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553 [TBL] [Abstract][Full Text] [Related]
36. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782 [TBL] [Abstract][Full Text] [Related]
37. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children]. Norero C; Delucchi A; Lagos E; Rosati P Rev Med Chil; 1996 May; 124(5):567-72. PubMed ID: 9035508 [TBL] [Abstract][Full Text] [Related]
38. Cyclosporin in the treatment of idiopathic nephrotic syndrome in children. Niaudet P; Habib R; Tete MJ; Hinglais N; Broyer M Pediatr Nephrol; 1987 Oct; 1(4):566-73. PubMed ID: 3153333 [TBL] [Abstract][Full Text] [Related]